Search

everythinglearnresearchcommunity

for

Search:↓

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.

The oral contraceptive with ethinyl estradiol and chlormadinone acetate is effective in treating moderate acne.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Compounds from certain trees used by First Nations people show potential for treating skin conditions and promoting hair growth, but more research is needed to confirm their safety and effectiveness.

A standard protocol for alopecia areata clinical trials was created to improve consistency and encourage more research.

Polyphenols may help treat skin conditions like warts, hair loss, acne, and dark spots, but more research is needed.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

UV radiation causes skin cancer, but sunscreens and certain drugs can help prevent it.

Propranolol is effective and safe for treating infantile hemangioma, but more research is needed for dosing and monitoring guidelines.

Minoxidil and spironolactone combo effectively treats androgenetic alopecia, improving hair density and diameter.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

New genes linked to ichthyosis were found, but there's still no cure; treatment options are improving.

Micrografts promote hair growth in androgenetic alopecia treatment.

Adenosine receptors could be promising targets for treating inflammatory skin diseases like psoriasis.

European guidelines recommend regular eye and ear exams, skin care, vitamin D supplements, and cautious use of medications for managing congenital ichthyoses.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Biologics show promise in treating various stubborn skin diseases, but more research and better reimbursement criteria are needed.

Androgenetic alopecia trials in the U.S. lack racial and ethnic diversity, limiting their applicability.

Finasteride helps increase or maintain hair in most men but can cause sexual side effects and should not be used by women, especially during pregnancy.

Clinical trials for hair loss in the USA show differences in participation among different races and ethnic groups.

Exosomes show promise for tissue repair and regeneration with advantages over traditional cell therapies.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Dutasteride works better than finasteride for hair loss, with both being safe to use.